Indiana University — Indianapolis, Indiana

Public research footprint of Indiana University, compiled from the ClinicalTrials.gov public registry.

3,134

Registered studies

773

Active

393

Recruiting now

1,821

Completed

469

Stopped or withdrawn

Most-studied conditions

Metastatic Non-Cutaneous Melanoma · Recurrent Melanoma · Resectable Pancreatic Acinar Cell Carcinoma · Recurrent Endometrial Clear Cell Adenocarcinoma

Recently updated registry entries

NCT03712605 — Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After… (Active Not Recruiting)
NCT01142388 — Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With… (Active Not Recruiting)
NCT05045820 — Integrative Medicine in Pain Management in Sickle Cell Disease (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Indiana University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.